Purdue: Discovery Points to New Approach to Treating Liver Cancer
December 05, 2023
December 05, 2023
WEST LAFAYETTE, Indiana, Dec. 5 (TNSres) -- Purdue University issued the following news release:
A breakthrough in the understanding of the relationship between a naturally occurring enzyme and the liver cancer drug sorafenib could improve the effectiveness of the drug, which currently prolongs the life of liver cancer patients for only two to three months. A study of the relationship between the enzyme DDX5, liver cancer and sorafenib, published in the Nature journal Cell Death &am . . .
A breakthrough in the understanding of the relationship between a naturally occurring enzyme and the liver cancer drug sorafenib could improve the effectiveness of the drug, which currently prolongs the life of liver cancer patients for only two to three months. A study of the relationship between the enzyme DDX5, liver cancer and sorafenib, published in the Nature journal Cell Death &am . . .